Meet the 2022/2023 PCI Fellows Cohort
Twelve fellows were admitted to the 2022/2023 cohort out of a large application pool. We also have three returning Sr. fellows from last year.
Penn Welcomes Ninth President to Campus
The Penn community gathered on College Green to welcome the new president.
Carisma Therapeutics continues to thrive and expand
Penn and Carisma Therapeutics (Carisma) have strengthened the intellectual property portfolio covering this technology with the issuance of five additional patents in 2022.
Staff Spotlight: Meet PCI’s Newest Team Members
Meet PCI's newest staff members and read their bios.
Penn ICorps Graduate and President’s Innovation Prize Winner Strella Biotech Raises $8 Million in Series A Funding Round
Read about how this Philadelphia-based agricultural biotech startup received funding from Mark Cuban, Google Ventures, and others.
Penn Spinout Regenxbio Opens New Gene Therapy Manufacturing Facility in Maryland
Regenxbio, a gene therapy company founded through collaboration with PCI, opened a new facility at its Maryland campus.
Abrax Japan licenses technology from Penn
Abrax Japan entered into an exclusive licensing agreement for certain Penn-owned inventions relating to the therapeutic effects of thymic stromal lymphopoietin (TSLP).
IBA partners with Penn Medicine to develop flash therapy
IBA Worldwide, a technology company that develops particle accelerator technology, partnered with a team of faculty from Radiation Oncology at Penn Medicine led by Dr. James Metz.
JPOD @ Philadelphia: Webinar Recording
Olivia McPherson, Program Manager, JPOD@PHILADELPHIA, shares how the JPOD and Johnson & Johnson's JLABS program helps startups with life science commercialization.
Webinar Recording: IP Trends for Emerging Penn Engineering Technologies
This webinar discusses the latest trends in intellectual property and patenting for engineers, including robotics, nanotechnology, med-tech and more